期刊
HUMAN GENE THERAPY
卷 28, 期 11, 页码 988-1003出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/hum.2017.160
关键词
AAV; lentivirus and other RNA viruses; cell-based therapies; clinical trials; delivery methods
资金
- NeurATRIS: A Translational Research Infrastructure for Biotherapies in Neurosciences
- Fondation pour la Recherche Medicale
- Bioingenierie pour la Sante [DBS20140930765]
- ParisBiotech Sante incubator
- SATT (Societe d'Acceleration de Transfert Technologique) Ile de France Innov
Clinical gene therapy has made important advances over the last decade. Among neurological diseases, severe genetic neurodegenerative conditions have been the focus of initial clinical applications. Gene therapy has also addressed complex neurodegenerative diseases, particularly Parkinson's disease, with encouraging results in human patients, demonstrating that specific targeting of central nervous system (CNS) cells is a relevant strategy for severe pathologies and that efficient access to the CNS with viral vectors is an achievable goal. The purpose of this review is to summarize the gene therapy clinical applications that have been conducted for neurodegenerative diseases. Limitations and hurdles to obtain and demonstrate benefit in patients, and the new developments that should allow new clinical applications with high beneficial potential are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据